| Lightcalls.com |
|
|
![]() |
In reading the literature, I raise...In reading the literature, I raise this interesting quote: "This (herb), which has slowly wedged its way into attention, is persistently forcing itself into conspicuity. The probabilities are that in a time to follow it will be ardently sought and widely used, for it is not single of the multitude that have flashed into sight, been artfully pushed, then investigated, plant wanting, and next dropped abroad of sight and out of mind." These words could have been written through any of the specialists in medicinal plants in late years. But they come to us from a time when echinacea was first becoming known. To be specific, they were written by dint of pharmacist, John Uri Lloyd (1849-1935) in 1904 Echinacea first introduced pharmacologically in 1895 Lloyd undivided of the most prominent historical figures in the history of American medicinal plants, introduced the first pharmaceutical preparations of echinacea in 1895 by the agency of his company Lloyd Brothers Pharmacists, Inc., of Cincinnati. Lloyd had first learned of echinacea in the mid-1880s when he and his botanist brother, Curtis Gates Lloyd received plant material from a self-styl physician in Pawnee City, beak -- Dr. H.C.F. Meyer. The latter made a patented medicinal life-current purifier that included the foundations of several plants whose uses he had learned from the Indians of Nebraska. united of those plants Meyer sent to the Lloyd for identification. Curtis Gates Lloyd identified the plant as Echinacea angustifolia. Meyer convinced of the herb's healing virtues, proffered to come to Cincinnati to demonstrate the plant's powers against snake bite on allowing himself to be bitten from a rattlesnake. The Lloyds declined the bizarre tender Instead, through the encouragement of Dr John King, an important 19th hundred years Eclectic physician, John Uri Lloyd made a preparation of the plant and gave it to Dr King for further investigation. The large number of extravagant claims made for the healing properties of echinacea eagerly prejudiced Lloyd against it. He wrote in part, that, "However, Dr King, with his usual thoughtfulnes consideration and care, propos to investigate the matter, and from the medicine forwarded by Dr. Meyer, I at formerly made for Dr. King several specimens of liquid preparations and then I passed the subdue from my mind as single in kind among a multitude of of that kind before me, destined to remain in obscurity." But in the same state [i]or[/i] condition was not to be the case. Dr King instead lay the foundation of the plant to be remarkably useful in his own clinical practice. In 1887 he authored the first article upon echinacea to appear in a medical journal, The Eclectic Medical Journal, alerting companion practitioners to its potential value. However, Lloyd remained a skeptic. Later, Lloyd wrote "Owing to what this writer now views as inexcusable conservatism, he persistently refused to introduce and distribute any echinacea preparation until a certain time after Dr. King had reported favorably concerning the action of the mix with drugs both in his home in the treatment of Mr King, and in general practice....My allow delay in its general introduction is to me now a expose of self-criticism." The words, quot at the opening of this article, written by way of John Uri Lloyd over 90 years ago, have approach to pass. Echinacea has forced its way into conspicuity, and has become, as Lloyd predicted, "ardently sought and widely used." In fact, it is now the best-selling herb in health and natural provender stores in the United States, as well as a rising star for the prevention and treatment of frigids and flu in the mass market. In fact, a individual of health food retailers and distributors published in the May 1995 issue of Health fodders Business found that echinacea was their overall best-selling product While the first echinacea issue Lloyd Brother's Specific Medicine Echinacea, as it was named, was introduced to the medical profession exactly 100 years ago, it was not previously unknown to human experience. Indian clumps of the prairies are known to have used echinacea species for more medicinal intents than any other native plant. It was used for chilleds snake bites and dozens of other conditions. Echinacea be delighted withs popularity, not only in the United States, nevertheless also in Europe. The first echinacea preparations actually appeared forward the German market in the late 1890 According to a new survey of European medicinal plant fruits it was revealed that individual echinacea product in Germany have the advantage [i]or[/i] blessing ofs over $30 million in annual sales. Over the past 60 years, European scientists, in Germany in particular, have investigated, and, in many instances, confirmed a rational scientific basis for the traditional medicinal use of the genus echinacea. That research has taken echinacea from the realm of a snake-bite relief to status as a non-specific stimulant to the immune system Echinacea includes nine species Echinacea (pronounced ek-i-nay-SEE-a) is a genus in the aster family, which includes nine species native and nothing else to the United States and toward the south central Canada. They grow in fields from Massachusetts to Georgia, west to Texas and eastern Montana. Six of the nine species are relatively rare. pair in fact, the Tennessee coneflower (Echinacea tennesseensis) and the smooth-leaved coneflower (Echinacea laevigata), are in succession the federal endangered species list. |
![]() |
Other Articles
-Morphotek will collaborat...-Eksigent Technologies nam... -The benefits of outsourci... -Sartorius Corporation ... -In our previous column, w... -Efoora appointed Michael ... -Affymax appointed Anne-Ma... -Traditionally, continuous... -New Brunswick Scientific ... -The German-American firm ... -Don G. Burstyn, formerly ... -American patients are mor... -Summary Prior to va... -BioPharm Editorial Adviso... -Australia agreed to spend... -The Biotechnology Industr... -Ambion, The RNA Company i... -Therapies based on living... -A recent survey found tha... -ViroLogic will acquire Ac... -Cardinal Health named Joh... -One of the greatest chall... -As the president of a sma... -Sweden-based Biovitrum wi... -Nanogen appointed David L... -The Experion Process Know... -Although biomedical resea... -The Supreme Court of Cana... -Netherlands-based DSM Bio... -David A. Smoller joined S... -A few months ago, I wrote... -Panacos Pharmaceuticals w... -Karen K. Vaccaro will res... -Acceleron Pharma appointe... -Two quarterly meetings of... -Illinois-based Abbot Labo... -FKI Logistics announced t... -The following corrections... -It its widest definition,... -UK-based Xcellsyz will li... -Andrew P. Aromando joined... -Invitrogen's comprehensiv... -Last month, we described ... -The Swiss life sciences c... -Protein Design Labs (PDL)... -Model It HNMR, the newest... -Tech transfer, like chang... -QLT and Atrix Laboratorie... -Dendreon announced Christ... -Baxter Pharmaceutical Sol... -The biopharmaceutical ind... -GlaxoSmithKline announced... -Montreal-based Caprion Ph... -Xenova Group recently ann... -Cole-Parmer's new 192-pag... -Over the last decade ther... -Benchmark your facility p... -As biotechnology organiza... -Frederick D. Sancillo, fo... -Insmed acquired a recombi... -Baxter Pharmaceutical Sol... -Model It HNMR, the newest... -DA's regulation 21 CFR Pa... -Robert P. Ryan joined Ath... -A new report from Busines... -Biotest offers a complete... -Swagelok offers a brochur... -Partnering is a global ph... -Human Genome Sciences CEO... -Shorten the process devel... -The licensure of biotechn... -Rodger Currie joined Amge... -The GEA Filtration Model ... -A multi-channel chemistry... -From June 6-9, San Franci... -Skanska USA Building Inc.... -New Brunswick Scientific'... -AVI BioPharma appointed P... -Ambion, The RNA Company, ... -"If you want to be a... -Xcellerex appointed Susan... -Researchers identified th... -Cool Spring Business Park... -In October 2003, Shenzhen... -Laureate Pharma appointed... -After a 6-5 vote by Calif... -QSourcing, a service of Q... -The recent discovery of &... -Affymax added Douglas L. ... -USDA recently approved tw... -BioPharm International is... -Serologicals has released... -This document by Shenzhen... -Robert Bronstein joined A... -Gloucester Gains Fujisawa... -With more than 30 years o... -Pall's SUPRAdisc II depth... -In today's competitive ma... -Protein Design Labs repor... -Charles A. Rice will repl... -AstraZeneca's Faslodex (f... |
| . |